<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03943186</url>
  </required_header>
  <id_info>
    <org_study_id>btph-014-2018-EHT02</org_study_id>
    <nct_id>NCT03943186</nct_id>
  </id_info>
  <brief_title>Application of Ectoin Containing Lozenges (EHT02) in Patients With Acute, Viral Pharyngitis.</brief_title>
  <official_title>Non-interventional Study to Investigate the Application of Ectoin Containing Lozenges (EHT02) in Patients With Acute, Viral Pharyngitis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bitop AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bitop AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this non-interventional study is to investigate the safety, efficacy and&#xD;
      tolerability of Ectoin Lozenges Honey Lemon (EHT02) compared to lozenges containing&#xD;
      hyaluronic acid and islandic moss in the treatment of acute viral pharyngitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current non-interventional study aims to investigate the efficacy and tolerability of&#xD;
      Ectoin Lozenges Honey Lemon in patients suffering from acute viral pharyngitis. Participants&#xD;
      receive treatments as part of routine medical care, and participants can choose one of two&#xD;
      treatment options: a) Ectoin Lozenges Honey Lemon or b) lozenges containing hyaluronic acid&#xD;
      and icelandic moss.&#xD;
&#xD;
      Efficacy will be studied by documentation of the following symptoms:&#xD;
&#xD;
        -  pain on swallowing&#xD;
&#xD;
        -  hoarseness&#xD;
&#xD;
        -  urge to cough&#xD;
&#xD;
        -  dry mouth and throat&#xD;
&#xD;
        -  redness of oropharynx and larynx&#xD;
&#xD;
        -  sore throat&#xD;
&#xD;
        -  impairment of free breathing&#xD;
&#xD;
        -  general feeling of illness&#xD;
&#xD;
      In parallel, participating patients will document their symptoms over the entire study&#xD;
      duration in patient diaries.&#xD;
&#xD;
      The observation takes place over a period of seven days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 13, 2018</start_date>
  <completion_date type="Actual">May 13, 2019</completion_date>
  <primary_completion_date type="Actual">May 13, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Pharyngitis symptom score evaluated by the physician</measure>
    <time_frame>day 1 and day 7</time_frame>
    <description>The intensity of the symptoms will be graded on a continuous numeric scale, i.e. absent-0, severe-10.&#xD;
The following signs and symptoms will be documented:&#xD;
pain on swallowing&#xD;
hoarseness&#xD;
urge to cough&#xD;
dry mouth and throat&#xD;
reddening of oropharynx&#xD;
reddening of larynx&#xD;
sore throat&#xD;
impairment of free breathing&#xD;
patient's general condition</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Pharyngitis Symptoms evaluated in patient's diaries</measure>
    <time_frame>7 days</time_frame>
    <description>The intensity of the symptoms and signs will be graded on a continuous numeric scale, i.e. absent-0, severe-10.&#xD;
The following signs and symptoms will be documented:&#xD;
pain on swallowing&#xD;
hoarseness&#xD;
urge to cough&#xD;
dry mouth and throat&#xD;
sore throat&#xD;
impairment of free breathing&#xD;
patient's general condition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Saliva production evaluated by the physician</measure>
    <time_frame>day 7</time_frame>
    <description>Assessment on a continuous numeric scale (0-no, 10-yes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation how efficient the treatment is judged by physician</measure>
    <time_frame>day 7</time_frame>
    <description>Assessment on a continuous numeric scale (0-bad, 10-very good)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation how efficient the treatment is judged by patient</measure>
    <time_frame>7 days</time_frame>
    <description>Assessment on a continuous numeric scale (0-bad, 10-very good)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation how treatment is tolerated (judged by physician)</measure>
    <time_frame>day 7</time_frame>
    <description>Assessment on a continuous numeric scale (0-bad, 10-very good)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation how treatment is tolerated (judged by patients)</measure>
    <time_frame>7 days</time_frame>
    <description>Assessment on a continuous numeric scale (0-bad, 10-very good)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of compliance evaluated by physician</measure>
    <time_frame>day 7</time_frame>
    <description>Assessment on a continuous numeric scale (0-bad, 10-very good)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of adverse events/serious adverse events</measure>
    <time_frame>7 days</time_frame>
    <description>All occuring adverse events/serious adverse events will be documented during the entire study period.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">102</enrollment>
  <condition>Acute Viral Pharyngitis</condition>
  <arm_group>
    <arm_group_label>Ectoin Lozenges Honey Lemon</arm_group_label>
    <description>application of 1 Lozenge every three hours or as often as required, not more than 10 lozenges per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyaluronic acid/Icelandic moss Lozenges</arm_group_label>
    <description>application as often as required, not more than 6 lozenges per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ectoin Lozenges Honey Lemon</intervention_name>
    <description>application of Ectoin Lozenges (EHT02) in accordance with the instructions for use</description>
    <arm_group_label>Ectoin Lozenges Honey Lemon</arm_group_label>
    <other_name>EHT02</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hyaluronic Acid/Icelandic moss Lozenges</intervention_name>
    <description>application of the lozenges in accordance with the instructions for use</description>
    <arm_group_label>Hyaluronic acid/Icelandic moss Lozenges</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients diagnosed with acute viral pharyngitis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with acute viral pharyngitis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with known intolerance to one of the substances used&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Surgical Procedures in the mouth and throat region prior to the study&#xD;
&#xD;
          -  Bacterial Pharyngitis&#xD;
&#xD;
          -  symptoms in the throat since more than 5 days&#xD;
&#xD;
          -  Contraindications according to the instructions for use&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Bilstein, Dr</last_name>
    <role>Study Director</role>
    <affiliation>CSO</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>bitop AG</name>
      <address>
        <city>Dortmund</city>
        <zip>44263</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>January 21, 2019</study_first_submitted>
  <study_first_submitted_qc>May 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 9, 2019</study_first_posted>
  <last_update_submitted>July 9, 2019</last_update_submitted>
  <last_update_submitted_qc>July 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>non-interventional study</keyword>
  <keyword>Ectoin</keyword>
  <keyword>Lozenges</keyword>
  <keyword>Pharyngitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharyngitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

